We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$1.65B
AUM Growth
+$199M
Cap. Flow
+$85.4M
Cap. Flow %
5.17%
Top 10 Hldgs %
20.98%
Holding
2,136
New
85
Increased
550
Reduced
505
Closed
122
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SECT icon
301
Main Sector Rotation ETF
SECT
$2.86B
$873K 0.05%
22,495
-366
-2% -$14.2K
ABLD
302
Abacus FCF Real Assets Leaders ETF
ABLD
$94.9M
$869K 0.05%
34,055
+9,702
+40% +$252K
DXCM icon
303
DexCom
DXCM
$31.3B
$847K 0.05%
7,479
-657
-8% -$72.1K
LUNA
304
DELISTED
Luna Innovations Incorporated
LUNA
$838K 0.05%
95,300
BSCN
305
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$831K 0.05%
39,607
+6,516
+20% +$136K
JETS icon
306
US Global Jets ETF
JETS
$803M
$830K 0.05%
48,592
AXP icon
307
American Express
AXP
$231B
$825K 0.05%
5,585
+730
+15% +$108K
ICLN icon
308
iShares Global Clean Energy ETF
ICLN
$2.37B
$825K 0.05%
41,552
DIA icon
309
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.3B
$824K 0.05%
2,486
+232
+10% +$75.4K
OXY icon
310
Occidental Petroleum
OXY
$55.7B
$820K 0.05%
13,024
+3,817
+41% +$260K
PRU icon
311
Prudential Financial
PRU
$41.9B
$818K 0.05%
8,221
-2,355
-22% -$239K
KRBN icon
312
KraneShares Global Carbon Strategy ETF
KRBN
$142M
$817K 0.05%
22,405
-175
-0.8% -$7.39K
ISRG icon
313
Intuitive Surgical
ISRG
$132B
$814K 0.05%
3,066
BOTZ icon
314
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.44B
$813K 0.05%
39,544
+14,666
+59% +$295K
IYW icon
315
iShares US Technology ETF
IYW
$24.8B
$802K 0.05%
10,762
SJM icon
316
J.M. Smucker
SJM
$12.7B
$800K 0.05%
5,049
+409
+9% +$60.9K
ED icon
317
Consolidated Edison
ED
$40.2B
$796K 0.05%
8,349
+472
+6% +$42.9K
WMB icon
318
Williams Companies
WMB
$87.8B
$791K 0.05%
24,039
-1,083
-4% -$35.3K
URA icon
319
Global X Uranium ETF
URA
$5.99B
$789K 0.05%
39,305
-1,494
-4% -$30.2K
MSOS icon
320
AdvisorShares Pure US Cannabis ETF
MSOS
$874M
$788K 0.05%
112,799
-1,300
-1% -$13.4K
REGN icon
321
Regeneron Pharmaceuticals
REGN
$79.5B
$784K 0.05%
1,086
-37
-3% -$27.3K
HYLB icon
322
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.47B
$779K 0.05%
23,110
+3,513
+18% +$119K
EWW icon
323
iShares MSCI Mexico ETF
EWW
$1.97B
$775K 0.05%
15,677
SOXX icon
324
iShares Semiconductor ETF
SOXX
$47.7B
$774K 0.05%
6,669
+420
+7% +$48.8K
SHW icon
325
Sherwin-Williams
SHW
$88.2B
$773K 0.05%
3,257
-20
-0.6% -$4.62K

Similar funds

Geneos Wealth Management's Q4 2022 Portfolio in Review

As of Q4 2022, Geneos Wealth Management held 2,136 positions worth $1.65B, up 14% from $1.45B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geneos Wealth Management deployed $85.4M of net new capital in Q4 2022, opening 85 new positions and adding to 550 existing holdings. Its largest new stake was Cambria Foreign Shareholder Yield ETF: 50,990 shares worth $1.24M.

By sector, the portfolio is most concentrated in Technology at 6.8% of assets, down from 7.4% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.88M trimmed.

  • Geneos Wealth Management's largest Q4 2022 buy was Cambria Foreign Shareholder Yield ETF: 50,990 shares worth $1.24M.
  • Geneos Wealth Management added most to iShares Russell 2000 ETF in Q4 2022, an estimated $7.83M increase.
  • Geneos Wealth Management's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.88M.
  • Geneos Wealth Management fully exited Brookfield in Q4 2022, selling an estimated $306K.
  • Geneos Wealth Management's ten largest holdings make up 21% of its $1.65B portfolio in Q4 2022.
  • Geneos Wealth Management opened 85 new positions and closed 122 in Q4 2022.
  • Geneos Wealth Management's portfolio value rose 14% quarter-over-quarter to $1.65B.

Based on Geneos Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.